Clinical-stage biotech developing combination cancer therapies
Arcus Biosciences is a public, clinical-stage biopharmaceutical company focused on combination medicines for cancer treatment. The tech stack reveals a research-first operation: Python and R for computational work, GraphPad Prism and ChemDraw for chemistry, HPLC and LC-MS for analytical chemistry, plus Streamlit and Shiny for interactive data visualization—typical of a discovery and early development stage. Hiring skews heavily toward research internships and senior scientists, with active projects spanning ADME modeling, pharmacology studies, and supply-chain optimization, indicating concurrent pressure to scale manufacturing and regulatory infrastructure.
Notable leadership hires: Director PV Science
Arcus Biosciences, headquartered in Hayward, California, develops differentiated small and large molecule therapeutics targeting immuno-oncology and cancer treatment. The company operates across discovery, preclinical development, and early clinical stages, with internal capabilities in medicinal chemistry, protein therapeutics, and formulation science. Projects span ex vivo sample preparation, high-throughput binding assays, in vivo pharmacology, and metabonomics workflows—alongside active work on trial master file compliance, safety reporting, and supply-chain process improvements. The workforce of 501–1,000 includes research scientists, clinical and regulatory personnel, and manufacturing staff, reflecting the operational breadth required of a clinical-stage public biotech.
Active projects include ADME computational modeling, high-throughput LC-MS assays for protein binding, in vivo pharmacology studies, route exploration, and supply-chain optimization. Safety and TMF compliance workflows are also underway.
Python, R, GraphPad Prism, ChemDraw, HPLC, LC-MS, Streamlit, Shiny, SAS, Unix, and Smartsheet. Tools reflect chemistry, analytical chemistry, and computational biology workflows.
Other companies in the same industry, closest in size